CUP (Carcinoma of Unknown Primary) Syndrome in Head and Neck: Clinic, Diagnostic, and Therapy

By  

Oncology Research and Treatment, Vol. 24, Iss. 1, 2001-03 ,pp. : 38-43

Karger

Access to resources Recommend Favorite

DNA aneuploidy‐specific therapy for head and neck squamous cell carcinoma

By  

HEAD & NECK: JOURNAL FOR THE SCIENCES & SPECIALTIES OF THE HEAD AND NECK, Vol. 37, Iss. 6, 2015-06 ,pp. : 884-888

John Wiley & Sons Inc

Access to resources Recommend Favorite

In vitro study of normoxic epidermal growth factor receptor–induced hypoxia‐inducible factor‐1‐alpha, vascular endothelial growth factor, and BNIP3 expression in head and neck squamous cell carcinoma cell lines: Implications for anti–epidermal growth factor receptor therapy

By  

HEAD & NECK: JOURNAL FOR THE SCIENCES & SPECIALTIES OF THE HEAD AND NECK, Vol. 37, Iss. 8, 2015-08 ,pp. : 1150-1162

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pharmacological genome demethylation increases radiosensitivity of head and neck squamous carcinoma cells

By            

International Journal of Molecular Medicine, Vol. 29, Iss. 3, 2012-01 ,pp. : 505-509

Spandidos Publications

Access to resources Recommend Favorite

Phase II Study of Cetuximab in Combination with Docetaxel in Patients with Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck after Platinum-Containing Therapy: A Multicenter Study of the Arbeitsgemeinschaft Internistische Onkologie

By  

Oncology, Vol. 84, Iss. 5, 2013-02 ,pp. : 284-289

Karger

Access to resources Recommend Favorite